Using Self-Aware Agilent InfinityLab LC/MSD iQ to Measure Trace-Level Impurities in a Brand Versus Generic Medication

Poster Reprint ASMS 2019 WP477 Growing MS adoption: A “Self-Driving” Mass Spectrometer Designed for NonExperts Enhance your Chromatography Results with Mass Detection for Unambiguous Confirmation of Analytes using Agilent’s InfinityLab LC/MSD iQ Single Quadrupole Kyle Covert, PhD, Maggie A. Ostrowski,…

High-Throughput LC/MS Purification of Pharmaceutical Impurities Application Note Small Molecule Pharmaceuticals Author Abstract Florian Rieck Legal regulations demand that organic impurities in pharmaceuticals must be Agilent Technologies, Inc. identified and characterized. The isolation of impurities from a pharmaceutical Waldbronn, Germany…

Application Note Biopharmaceuticals Peptide Drug Stability Analysis Using Agilent InfinityLab LC/MSD and OpenLab CDS Deconvolution Author Chae-Young Ryu Agilent Technologies, Inc. Abstract The Federal Drug Administration (FDA) abbreviated new drug application (ANDA) guidelines advise qualitative and quantitative management of peptide-related…

Application Note Pharma & Biopharma Efficient Purification of Crude Samples in Early-Stage Drug Discovery Using the Agilent 1290 Infinity II Preparative LC/MSD System Authors Sonja Schipperges and Florian Rieck Agilent Technologies, Inc. Abstract In early-stage drug discovery, high-purity compounds are…